Evidence map›Paper›PMID 39491720›Full record

ArticleContemporary clinical trials2024

Lifestyle empowerment for Alzheimer's prevention prescribed by physicians: Methods and adaptations to COVID-19.

Amanda N Szabo-Reed, Amber Watts, Eric D Vidoni, Jonathan Mahnken, Angela Van Sciver, Katrina Finley, Jonathan Clutton, Rachel Holden, Mickeal N Key, Jeffery M Burns

Abstract readClinical Trial Protocol
In one paragraph

Article in Contemporary clinical trials, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Trial
  2. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Amanda N Szabo-ReedPhysical Activity & Weight Management, University of Kansas Medical Center, 3901 Rainbow Boulevard, Kansas City, KS 66160, USA. Electronic address: aszabo@kumc.edu.
Amber WattsDepartment of Psychology, University of Kansas, 1415 Jayhawk Boulevard, Lawrence, KS 66045, USA; University of Kansas Alzheimer's Disease Research Center, 4350 Shawnee Mission Parkway, Fairway, KS 66205, USA. Electronic address: amberwatts@ku.edu.
Eric D VidoniUniversity of Kansas Alzheimer's Disease Research Center, 4350 Shawnee Mission Parkway, Fairway, KS 66205, USA. Electronic address: evidoni@kumc.edu.
Jonathan MahnkenDepartment of Biostatistics and Data Science, University of Kansas Medical Center, 3901 Rainbow Boulevard, Kansas City, KS 66160. Electronic address: jmahnken@ku.edu.
Angela Van SciverUniversity of Kansas Alzheimer's Disease Research Center, 4350 Shawnee Mission Parkway, Fairway, KS 66205, USA. Electronic address: avansciver@kumc.edu.
Katrina FinleyUniversity of Kansas Alzheimer's Disease Research Center, 4350 Shawnee Mission Parkway, Fairway, KS 66205, USA.
Jonathan CluttonUniversity of Kansas Alzheimer's Disease Research Center, 4350 Shawnee Mission Parkway, Fairway, KS 66205, USA. Electronic address: jclutton@kumc.edu.
Rachel HoldenUniversity of Kansas Alzheimer's Disease Research Center, 4350 Shawnee Mission Parkway, Fairway, KS 66205, USA. Electronic address: rholden@kumc.edu.
Mickeal N KeyUniversity of Kansas Alzheimer's Disease Research Center, 4350 Shawnee Mission Parkway, Fairway, KS 66205, USA. Electronic address: mkey@kumc.edu.
Jeffery M BurnsUniversity of Kansas Alzheimer's Disease Research Center, 4350 Shawnee Mission Parkway, Fairway, KS 66205, USA. Electronic address: jburns2@kumc.edu.

Funding

RADx-UP: Improving the Response of Local Urban and Rural Communities to Disparities in Covid-19 TestingUL1TR002366 · NCATS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI Mario Castro, JAMES STEVEN LEEDER · 2017 to 2026
$44.3M
University of Kansas Alzheimer's Disease Research Center (KU ADRC)P30AG072973 · NIA · UNIVERSITY OF KANSAS MEDICAL CENTER · PI Mohammad Haeri · 2021 to 2026
$25.3M
Prescribing Smart Aging: Integrating Health Systems with Community-Based Lifestyle InterventionsR01AG052954 · NIA · UNIVERSITY OF KANSAS MEDICAL CENTER · PI BURNS, JEFFREY MURRAY · 2017 to 2021
$2.9M
Multidisciplinary Research Training Program in Alzheimer's Disease and Related DisordersT32AG078114 · NIA · UNIVERSITY OF KANSAS MEDICAL CENTER · PI Sandra A Billinger, Eric Dennis Vidoni · 2022 to 2026
$1.2M
NCATS NIH HHS UL1 TR002366NIA NIH HHS P30 AG072973NIA NIH HHS R01 AG052954NIA NIH HHS T32 AG078114
6 · The paper itself

Abstract

The health care system is insufficiently capitalizing on the benefits of physical exercise in America's aging population. Few tools exist to help clinicians incorporate physical activity into their clinical care, and barriers limit older adults from initiating and maintaining exercise programs. The Lifestyle Empowerment for Alzheimer's Prevention (LEAP! Rx) Program has been designed to support providers and participants in lifestyle change. LEAP! Rx uses two forms of participant enrollment: physician referrals through electronic health records and self-referrals to test the efficacy of delivering a community-based exercise and healthy lifestyle program to older adults. After referral into the program, participants are randomized to receive the LEAP! Rx Program or are placed in a standard-of-care group to receive the program later. The LEAP! Rx program consists of a personalized and structured exercise program, lifestyle education, and mobile health monitoring. This includes a 12-week Empowerment phase with coaching and supervised exercise training, followed by a 40-week Lifestyle phase with intermittent supervised exercise and coaching. Lifestyle education includes monthly, evidence-based classes on optimal aging. The evaluation of LEAP! Rx focuses on 1) the assessment of implementation and scalability of the LEAP!Rx Program for clinicians and patients 2) the effect of the LEAP! Rx Program on cardiorespiratory fitness, 3) the impact of the LEAP! Rx Program on secondary intervention outcome measures of chronic disease risk factors, including insulin resistance, body composition, and lipids. If successful, this study's findings could advance future healthcare practices, providing a new and practical approach to aging and chronic disease prevention.

Indexed as

Alzheimer DiseaseCOVID-19ExerciseAgedEmpowermentExercise TherapyFemaleHealthy LifestyleHumansLife StyleMaleRandomized Controlled Trials as TopicSARS-CoV-2TelemedicineCardiorespiratory fitnessExerciseExercise prescriptionHealth care deliveryHealthy lifestyleInterventionPhysical activityRCTRecruitment

Identifiers

PMID39491720
PMCPMC11932157

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.